Search clinical trials for: Varenicline (Chantix)

Total 354 results

Sahlgrenska University Hospital, Sweden
Karolinska University Hospital; Malmö University

Completed

Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?

Alcohol Dependence

Sweden
Pfizer

Withdrawn

A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia

Schizophrenia
Pfizer

Completed

A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.

Smoking Cessation

United States
Pfizer

Completed

ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking (ASIA CHOICES)

Smoking Cessation

Korea, Republic of, China, Philippines, India
Pfizer

Completed

Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo

Smoking Cessation

United States
Pfizer

Completed

Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

Smoking Cessation

United States, France, Italy, Spain
Mark Eisenberg
Sunnybrook Health Sciences Centre; Unity Health Toronto; Queen Elizabeth II Health...

Completed

Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial (EVITA)

Acute Coronary Syndrome

Canada
Pfizer

Completed

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets

Smoking Cessation
Pfizer

Completed

Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan)

Smoking Cessation
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR); Canadian Tobacco Control Research...

Completed

Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder

Nicotine Dependence

Canada
Pfizer

Completed

Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date

Smoking Cessation

United States, Czech Republic, Korea, Republic of, Brazil, Taiwan, Mexico, France, Italy, Hungary, Germany, Canada, China, Argentina, United Kingdom
Pfizer

Completed

Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression

Depression | Smoking Cessation

Spain, United States, Hungary, Germany, Bosnia and Herzegovina, Croatia, Romania, Russian Federation
Pfizer

Completed

Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects

Healthy | Non-Smoking

United States
Pfizer

Completed

A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers

Smoking Cessation

United States, United Kingdom
The Queen Elizabeth Hospital

Completed

Smoking Termination Opportunity for inPatients (STOP)

Tobacco Use Disorder

Australia
NYU Langone Health
Pfizer

Withdrawn

Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt (VarenSmoke)

Nicotine Dependence

United States
Pfizer
Karolinska Institutet; University of Aarhus

Completed

Varenicline Pregnancy Cohort Study

Malformations
Pfizer

Completed

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Smoking Cessation

United States, Canada
University of British Columbia
Provincial Health Services Authority

Withdrawn

Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)

Schizophrenia | Psychosis | Schizoaffective
Pfizer

Completed

Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)

Smoking Cessation
Pfizer

Completed

Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking

Smoking Cessation

United States, Korea, Republic of, Brazil, Australia, Canada, United Kingdom, France, Czech Republic, Germany, Greece, Netherlands, Denmark, Taiwan, Argentina, Mexico
Centre for Addiction and Mental Health
Pfizer

Completed

Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia

Smoking | Schizophrenia | Craving

Canada
Pfizer

Completed

Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease

Alzheimer's Disease

Korea, Republic of
Shaare Zedek Medical Center

Completed

Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?

Smoking Cessation

Israel
Queen Mary University of London

Completed

Tailoring Varenicline to Individual Needs (TVIN Study) (TVIN)

Smoking Cessation | Tobacco Dependence

United Kingdom
Massachusetts General Hospital

Terminated

Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)

Smoking Cessation | Attention Deficit/Hyperactivity Disorder
Pfizer

Completed

A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking

Smoking

Japan
Mayo Clinic

Completed

Varenicline Treatment for Active Alcoholic Smokers

Smoking | Alcohol Dependence | Tobacco Dependence

United States
Pfizer

Completed

Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

Tobacco Use Cessation

Norway, Sweden
Centre for Addiction and Mental Health
Ontario Lung Association

Completed

Varenicline in Drug Treatment (ViRT)

Smoking Cessation | Alcohol Abuse

Canada
Pfizer

Completed

Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking

Smoking Cessation

Colombia, Mexico, Egypt, Jordan, Brazil, Costa Rica, Lebanon, Saudi Arabia, South Africa, United Arab Emirates, Venezuela
Pfizer

Completed

Post Marketing Surveillance Study of Champix in Smoking Cessation for Filipino Patients

Smoking Cessation
Yale University

Terminated

Smoking Cessation Treatment for Head and Neck Cancer Patients

Smoking Cessation

United States
Mayo Clinic

Completed

Varenicline For Smokers In Recovery From Alcohol Dependence

Tobacco Abstinence

United States
University Health Network, Toronto
Pfizer

Unknown

Smoking Cessation Program in the Preadmission Clinic

Smoking

Canada
Centre for Addiction and Mental Health
Pfizer

Completed

Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Canada
American University of Beirut Medical Center
Pfizer

Completed

Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation

Nicotine Dependence

Lebanon
Butler Hospital
Brown University

Completed

Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers

Depressive Disorder | Smoking

United States
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Nabi...

Completed

Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)

Smoking Behavior | Smoking Lapse Behavior | Smoking Relapse Behavior

Netherlands
Pfizer

Completed

Varenicline Observational Investigation In The Cessation of Smoking (CHOICES)

Smoking Cessation

Belgium, Hungary, Greece, Slovenia
Mayo Clinic
National Institutes of Health (NIH)

Completed

Varenicline for the Treatment of Smokeless Tobacco (CHANCHEW)

Nicotine Dependence

United States
Medical University of South Carolina

Completed

Hollings Cancer Center Varenicline Sampling Study

Smoking | Smoking Cessation | Smoking, Tobacco | Smoking, Cigarette

United States
Medical University of South Carolina

Completed

Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers (GRAND)

Nicotine Dependence

United States
Butler Hospital
Brown University

Withdrawn

Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients

Depressive Disorder | Smoking

United States
Roswell Park Cancer Institute
Pfizer

Completed

An Alternative Dosing Schedule of Varenicline for Smoking Cessation

Smoking Cessation

United States
Nathan Kline Institute for Psychiatric Research

Completed

Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors

Schizophrenia | Cigarette Smoking

United States, China, Israel
Johns Hopkins University
Pfizer

Completed

Relapse Prevention With Varenicline (0815)

Substance-Related Disorders | Smoking Cessation | Recurrence

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Completed

Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement

Tobacco Dependence

United States
Sheba Medical Center
Hadassah Medical Organization; Barzilai Medical Center

Unknown

Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS

Smoking Cessation | Acute Coronary Syndrome

Israel
University of Minnesota

Completed

Improving Varenicline Adherence and Outcomes in Homeless Smokers

Tobacco Use Cessation

United States

Search clinical trials for: Varenicline (Chantix)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations